杀破狼

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

一 |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。    《剑星》MOD 社区再度迎来高质量新作。国外模组大神发布了一款名为 "A51 Cyber Magician Trickster Illusionist" 的伊芙外观 MOD，以赛博魔法师为主题，提供了丰富的身体与服装自定义选项。    N站下载地址>>>这款 MOD 共包含六项核心修改内容：一是普通身体皮肤替换，二是水润光泽质感身体皮肤，三是身体参数自定义调整，四是去除丝袜效果，五是去除尾巴装饰，六是对部分服装进行了细节修改。

二 | 玩家可根据个人喜好自由组合，打造专属的伊芙造型。作者特别提醒，该 MOD 与同类功能 MOD 存在兼容性冲突，使用时需注意避免重复加载。作品展示：     本文由游民星空制作发布，未经允许禁止转载。更多相关资讯请关注：剑星专区。

Current article:http://h3efwk3.rangnehongranlinren.bond/news/20260826_245443.html

Published on:10:26:47